Advertisement

Journal of Neural Transmission

, Volume 71, Issue 3, pp 195–205 | Cite as

Thyroid hormone and norepinephrine: Effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart

  • A. C. Swann
Original Papers

Summary

Thyroid hormone produces metabolic effects similar to those of stimulation of noradrenergic receptors. It has been reported, however, that norepinephrine turnover is reduced during thyrotoxicosis and that beta-noradrenergic receptor number is increased. Metabolic effects of thyroid hormone may therefore reduce noradrenergic activity. We examined effects of thyroid hormone administration or production of hypothyroidism with methimazole on receptors associated with regulation of noradrenergic function. Treatment with thyroid hormone increased beta-receptor binding, increased alpha-2 receptor binding, and decreased desipramine binding, opposite to effects of hypothyroidism produced by methimazole. Heart was more sensitive than brain to these effects. These data are consistent with reduced noradrenergic activity during hyperthyroidism, possibly mediated by an increase in autoreceptor function.

Keywords

Thyroid hormone methimazole noradrenergic receptors desipramine clonidine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler CH, Meller E, Goldstein M (1987) Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex. J Pharmacol Exp Ther 240: 508–515Google Scholar
  2. Anden NE, Pauksens K, Svensson K (1982) Selective blockade of brain alpha-2 autoreceptor by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine. J Neural Transm 55: 111–120Google Scholar
  3. Atterwill CK, Bunn SJ, Atkinson DJ, Smith SL, Heal DJ (1984) Effects of thyroid status on presynaptic alpha-2-adrenoceptor function and beta-adrenoceptor binding in the rat brain. J Neural Transm 59: 43–55Google Scholar
  4. Biegon A, Rainbow TC (1983) Localization and characterization of3H-desmethylimipramine binding sites in rat brain by quantitative autradiography. J Neurosci 3: 1069–1076Google Scholar
  5. Bilezikian, JP, Loeb JN, Gammon DE (1979) The influence of hyperthyroidism and hypothyroidism on the beta-adrenergic responsiveness of the turkey erythrocyte. J Clin Invest 63: 184–192Google Scholar
  6. Bilezikian JP, Loeb JN (1982) Mechanisms of altered beta-adrenergic responsiveness in the hypothyroid and hypothyroid turkey erythrocyte. Life Sci 30: 663–673Google Scholar
  7. Bilezikian JP, Loeb JN (1983) The influence of hyperthyroidism and hypothroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocrine Rev 4: 378–388Google Scholar
  8. Cedarbaum JM, Aghajanian GK (1977) Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol 44: 375–385Google Scholar
  9. Curet O, Dennis T, Scatton B (1987) Evidence for the involvement of presynaptic alpha-2 adrenoceptors in the regulation of norepinephrine metabolism in rat brain. J Pharmacol Exp Ther 240: 327–336Google Scholar
  10. Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha-2 receptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241: 642–649Google Scholar
  11. Farnebo LO, Hamberger B (1970) Effects of desipramine, phentolamine, and phenoxy-benzamine on the release of adrenaline from isolated terminals. Biochem Pharmacol 22: 855–857Google Scholar
  12. Gross G (1979) Influence of hypothyroidism on adrenoceptor-mediated reactions in the cerebral cortex of the rat. Naunyn Schmiedebergs Arch Pharmacol 308: R11Google Scholar
  13. Gross G, Brodde O-F, Schumann H-J (1980) Decreased number of beta-adrenoceptors in cerebral cortex of hypothyroid rats. Eur J Pharmacol 61: 191–194Google Scholar
  14. Gross G, Lues I (1985) Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responses of the rat. Naunyn Schmiedebergs Arch Pharmacol 329: 427–439Google Scholar
  15. Heal DJ, Smith SDL, Atterwill CK (1984) Effects of thyroid status on clonidine-induced hypoactivity responses in the developing rat. J Neural Transm 60: 295–302Google Scholar
  16. Hoovler DW, Hwang BH, Demers LM (1985) Effects of triiodothyronine and propylthiouracil on regeneration of catecholaminergic nerve terminals in the paraventricular hypothalamic nucleus of the adult rat. Exp Neurol 89: 123–133Google Scholar
  17. Hrdina PV, Elson-Hartman K, Roberts DCS, Pappas BA (1981) High affinity3-desipramine binding in rat cerebral cortex decreases with selective lesion of noradrenergic neurons with 6-hydroxydopamine. Eur J Pharmacol 73: 375–376Google Scholar
  18. Kitamura Y, Nomura Y (1985) Beta-adrenoceptor stimulation-induced increase in the number of alpha-2 adrenoceptors of cerebral cortical membranes in rats. Brain Res 329: 259–264Google Scholar
  19. Langer SZ, Raismann R, Briley M (1981) High-affinity3H-DMI binding is associated with neuronal noradenaline uptake in the periphery and the central nervous system. Eur J Pharmacol 72: 423–424Google Scholar
  20. Lee CM, Javitch JA, Snyder SH (1982) Characteristics of [3H] desipramine binding associated with neuronal norepinephrine reuptake sites in rat brain membranes. J Neurosci 2: 1515–1525Google Scholar
  21. Lee CM, Javitch JA, Snyder SH (1983) Recognition sites for norepinephrine reuptake: regulation by transmitter. Science 220: 626–629Google Scholar
  22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein determination using the Folin phenol reagent. J Biol Chem 193: 265–275Google Scholar
  23. Maggi A, U'Prichard DC, Enna SJ (1980) Beta-adrenergic regulation of alpha-2 adrenergic receptors in the central nervous system. Science 207: 645–647Google Scholar
  24. Malbon CC, Moreno FJ, Cabelli RJ, Fain JN (1978) Fat cell adenylate cyclase and beta-adrenergic receptors in altered thyroid states. J Biol Chem 253: 671–678Google Scholar
  25. Malbon CC, Graziano MP, Johnson GL (1984) Fat cell beta-adrenergic receptor in the hypothyroid rat: impaired interaction with the stimulatory regulatory component of adenylate cyclase. J Biol Chem 259: 3254–3260Google Scholar
  26. Medina JH, Wolfman C, Levi de Stein M, Tumilasci O, Houssay AB (1984) Thyroid hormone regulation of adrenergic receptors and beta-adrenergic responsiveness in rat submandibularl gland. Life Sic 35: 819–825Google Scholar
  27. Mulder AH, de Langen CDJ, de Regt V, Hogenboom F (1978) Alpha-receptor-mediated modulation of3H-noradrenaline release from rat brain cortex synaptosomes. Naunyn Schmiedebergs Arch Phamacol 303: 193–196Google Scholar
  28. Nilsson OR, Karlberg BE (1983) Thyroid hormones and the adrenergic nervous system. Acta Med Scand [Suppl] 627: 27–32Google Scholar
  29. Nomura Y, Kawai M, Segawa T (1984) The interaction between beta- and alpha-2 adrenoceptors n cerebral cortical membranes: isoproterenol-induced increase in [3H] clonidine binding in rats. Brain Res 302: 101–109Google Scholar
  30. Raiteri M, Mauro G, Versace P (1984) Functional evidence for two stereochemically different alpha-2 adrenergic receptors regulating central norepinephrine and serotonin release. J Pharmacol Exp Ther 224: 679–684Google Scholar
  31. Rehavi M, Skolnick P, Brownstein MJ, Paul SM (1982) High affinity binding of (3H) desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites. J Neurochem 38: 889–895Google Scholar
  32. Rodbell M (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284: 17–22Google Scholar
  33. Slotkin TA, Slepatis RJ (1984) Obligatory role of thyroid hormone in development of peripheral sympathetic and central catecholaminergic neurons: effect of propylthiour-acil-induced hypothyroidism on transmitter levels, turnover, and release. J Pharmacol Exp Ther 230: 53–61Google Scholar
  34. Sokoloff L (1971) The action of thyroid hormones. In: Lajtha A (ed) Handbook of neurochemistry, vol 5 B. Plenum, New York, pp 525–547Google Scholar
  35. Swann AC (1985) (Na+, K+)-ATPase and noradrenergic regulation: effects of cardiac glycoside treatment and noradrenergic manipulations. Eur J Pharmacol 119: 67–74Google Scholar
  36. Swann AC (1984) (Na, K)-Adenosine triphosphatase regulation by the sympathetic nervous system: effects of noradrenergic stimulation and lesions in vivo. J Pharmacol Exp Ther 228: 304–311Google Scholar
  37. Swann AC, Grant S, Hattox SE, Maas JW (1981) Adrenoceptor regulation in rat brain: chronic effects of alpha-1 and alpha-2 receptor blockers. Eur J Pharmacol 213: 481–485Google Scholar
  38. Swann AC, Duman R, Hewitt L (1985) Desipramine binding: relationship to central and sympathetic noradrenergic activity. J Neurochem 44: 611–615Google Scholar
  39. Terry LC (1986) Regulation of thyrotropin secretion by the central epinephrine system. Studies in the chronically cannulated rat. Neuroendocrinology 42: 102–108Google Scholar
  40. U'Prichard DC, Greenberg DA, Snyder SH (1977) Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol 13: 454–473Google Scholar
  41. U'Prichard DC, Reisine TD, Mason ST, Fibiger HC, Yamamura HI (1980) Modulation of rat brain alpha- and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle. Brain Res. 180: 143–154Google Scholar
  42. Whybrow PC, Prange AJ (1981) A hypothesis of thyroid-catecholamine-receptor interaction. Arch Gen Psychiatry 38: 106–113Google Scholar
  43. Williams WT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr (1977) Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 252: 2787–2789Google Scholar
  44. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York, pp 201–204Google Scholar
  45. Woodcock EA, Johnston CL (1982) Characterization of adenylate cyclase-coupled alpha-2-adrenergic receptors in rat renal cortex using [3H]yohimbine. Mol Pharmacol 22: 589–594Google Scholar

Copyright information

© Springer Verlag 1988

Authors and Affiliations

  • A. C. Swann
    • 1
  1. 1.Department of PsychiatryUniversity of Texas Medical SchoolHoustonUSA

Personalised recommendations